Capital expenditure · 2019–2025
Pharming Group capital expenditure
$749,000−5.2% · FY2025
Pharming Group (PHAR) reported $749,000 in capital expenditure for fiscal 2025, −5.2% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $749,000 | −5.2% | Open → |
| FY20242024-12-31 | $790,000 | −45.0% | Open → |
| FY20232023-12-31 | $1.4M | +4.4% | Open → |
| FY20222022-12-31 | $1.4M | −87.2% | Open → |
| FY20212021-12-31 | $10.7M | +130.6% | Open → |
| FY20202020-12-31 | $4.7M | +75.9% | Open → |
| FY20192019-12-31 | $2.6M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth −19.0%
Figures are reported under IFRS, in US dollars.
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pharming Group capital expenditure |url=https://companiesranked.com/en/company/pharming-group/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pharming Group capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/pharming-group/capital-expenditureBibTeX
@misc{companiesranked-en-company-pharming-group-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Pharming Group capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pharming-group/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001828316-26-000015 · April 2, 2026
{{cite web |title=Pharming Group capital expenditure — 20-F (0001828316-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1828316/000182831626000015/pharm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-04-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.